A specific spectrum of p53 mutations in lung cancer from smokers: Review of mutations compiled in the IARC p53 database

Environmental Health Perspectives

Volumn 106, Issue 7, 1998, Pages 385-391

  Hernandez Boussard, Tina M ^a   Hainaut, Pierre ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Benzo(a)pyrene; Lung cancer; Nonsmokers; p53 mutations; Tobacco

Indexed keywords

BENZO[A]PYRENE; POLYCYCLIC AROMATIC HYDROCARBON; TOBACCO SMOKE;

ARTICLE; CODON; DATA BASE; DNA ADDUCT; EXPOSURE; GENE MUTATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SMOKING; TUMOR SUPPRESSOR GENE;

EID: 0031758362     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.98106385     Document Type: Article

References (52)

1. Kondo K, Tsuzuki M, Sasa M, Sumitomo M, Uyama T, Monden Y, A dose-response relationship between the frequency of p53 mutations and tobacco consumption in lung cancer patients. J Surg Oncol 61:20-26 (1996).
2. Wynder E, Hoffmann D. Smoking and lung cancer:scientific challenges and opportunities. Cancer Res 54:5284-5295 (1994).
3. Parkin DM, Pisani P, Lopez AD, Masuyer E. At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer 59:494-504 (1994).
4. Hammond EC. Smoking in relation to the death rates of one million men and women. Natl Cancer Inst Monogr 19:127-204 (1966).
5. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking:40 years' observations on male British doctors. Br Med J 309:901-911 (1994).
6. McLaughlin JK, Hrubec Z, Blot WJ, Fraumeni JF Jr. Smoking and cancer mortality among U.S. veterans:a 26-year follow-up. Int J Cancer 60:190-193 (1995).
7. Vineis P, Caporaso N. Tobacco and cancer:epidemiology and the laboratory. Environ Health Perspect 103:156-160 (1995).
8. IARC, IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. Vol 38:Tobacco Smoking. Lyon:International Agency for Research on Cancer, 1986.
9. IARC. Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. Vol 34:Polynuclear Aromatic Hydrocarbons, Part 3:Industrial Exposures in Aluminium Production, Coal Gasification, Coke Production, and Iron and Steel Founding. Lyon:International Agency for Research on Cancer, 1984.
10. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 Mutations in human cancers. Science 253:49-53 (1991).
11. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene:clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878 (1994).
12. Lehman T, Greenblatt M, Bennett WP, Harris C. Mutational spectrum of the p53 tumor suppressor gene:clues to cancer etiology and molecular pathogenesis. Drug Metab Rev 26:221-235 (1994).
13. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 253:49-53 (1991).
14. Hainaut P, Hernandez T, Robinson A, Rodriguez-Tome P, Flores T, Hollstein M, Harris CC, Montesano R. IARC database of p53 mutations in human tumors and cell lines:updated compilation, revised formats and new visualization tool. Nucleic Acids Res 26:205-213 (1998).
15. Hartmann A, Blaszyk H, Kovach JS, Sommer SS. The molecular epidemiology of p53 gene mutations in human breast cancer. Trends Genet 13:27-33 (1997).
16. Jones PA, Buckley JD, Henderson BE, Ross RK, Pike MC. From gene to carcinogen:a rapidly evolving field in molecular epidemiology. Cancer Res 51:3617-3620 (1991).
17. Dogliotti E. Mutational spectra:from model systems to cancer-related genes, Carcinogenesis 17:2113-2118 (1996).
18. Palombo F, Kohfeldt E, Calcagnile A, Nehls P, Dogliotti E, N-methyl-N-nitrosourea-induced mutations in human cells. Effects of the transcriptional activity of the target. J Mol Biol 223:587-594 (1992).
19. McGregor W, Chen R, Lukash L, Maher V, McCormick J. Cell cycle-dependent strand for UV-induced mutations in the transcribed strand of excision repair-proficient human fibroblasts but not in repair deficient-cells. Mol Cell Biol 11:1927-1934 (1991).
20. Pfeifer G, Homquist G, Mutagenesis in the p53 gene. Biochim Biophys Acta 1333:M1-M8 (1997).
21. Denissenko M, Pao A, Pfeifer G, Tang MS. Slow repair of bulky DNA adducts along the non-transcribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers. Oncogene 16(10):1241-1247 (1998).
22. Ruggeri B, DiRado M, Zhang SY, Bauer B, Goodrow T, Klein-Szanto AJ. Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene. Proc Natl Acad Sci USA 90(3):1013-1017 (1993).
23. Essigmann JM, Wood ML The relationship between the chemical structures and mutagenic specificities of the DNA lesions formed by chemical and physical mutagens.Toxicol Lett 67(1-3):29-39 (1993).
24. Puisieux A, Lim S, Groopman J, Ozturk M. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res 51(22):6185-6189 (1991).
25. Ronai ZA, Gradia S, Peterson LA, Hecht SS. G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents. Carcinogenesis 14(11):2419-2422 (1993).
26. Kure EH, Ryberg D, Hewer A, Phillips DH, Skaug V, Baera R, Haugen A. p53 Mutations in lung tumours:relationship to gender and lung DNA adduct levels. Carcinogenesis 17:2201-2205 (1996).
27. Husgafvel-Pursiainen K, Ridanpää M, Anttila S, Vainio H. p53 and ras gane mutations in lung cancer:implications for smoking and occupational exposures. J Occup Environ Med 37(1):69-76 (1995).
28. Fraumeni J, Blot W. Cancers of the lung and pleura. In:Cancer Epidemiology and Prevention (Schottenfeld D, Fraumeni JF, eds). New York:Oxford University Press, 1996;637-665.
29. Patel AR, Obrams GI. Adenocarcinoma of the lung. Cancer Epidemiol Biomarkers Prev 4:175-180 (1995).
30. Denissenko MF, Pao A, Tang MS, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 274:430-432 (1996).
31. Denissenko MF, Chen JX, Tang MS, Pfeifer GP. Cytosine methylation determines hot spots of DNA damage in the human p53 gene. Proc Natl Acad Sci USA 94:3893-3898 (1997).
32. Montesano R, Hainaut P, Wild C, Hepatocellular carcinoma:from the gene to public health. J Natl Cancer Inst 89:1844-1851 (1997).
33. Taylor JA, Watson MA, Devereux TR, Michels RY, Saccomanno G, Andersen M. p53 Mutation hots pot in radon-associated lung cancer. Lancet 343:86-87 (1994).
34. Vahakangas KH, Samet JM, Metcalf RA, Welsh JA, Bennett WP, Lane DP, Harris CC, Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet 339:576-580 (1992).
35. Bartsch H, Hollstein M, Mustonen R, Schmidt J, Spiethoff A, Wasch H, Wiethege T, Muller KM. Screening for putative radon-specific p53 mutation hotspot in German uranium miners [letter]. Lancet 346:121 (1995).
36. Husgafvel-Pursiainen K, Kannio A, Cigarette smoking and p53 mutations in lung cancer and bladder cancer. Environ Health Perspect 104(suppl 31:553-556 (1996).
37. Takeshima Y, Seyama T, Bennett WP, Akiyama M, Tokuoka S, Inai K, Mabuchi K, Land CE, Harris CC. p53 Mutations in lung cancers from non-smoking atomic-bomb survivors. Lancet 342:1520-1521 (1993).
38. Guinee DG Jr, Travis WD, Trivers GE, De Benedetti VM, Cawley H, Welsh JA, Bennett WP, Jett J, Colby TV, Tazelaar H, et al. Gender comparisons in human lung cancer:analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression. Carcinogenesis 16:993-1002 (1995).
39. Ryberg D, Hewer A, Phillips DH, Haugen A. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res 54:5801-5803 (1994).
40. Bartsch H, Hietanen E. The role of individual susceptibility in cancer burden related to environmental exposure. Environ Health Perspect 104 (suppl 31:569-577 (1996).
41. DeMarini DM, Shelton ML, Levine JG. Mutation spectrum of cigarette smoke condensate in Salmonella:comparison to mutations in smokingassociated tumors, Carcinogenesis 16:2535-2542 (1995).
42. Mazur M, Glickman BW, Sequence specificity of mutations induced by benzo[a]pyrene-7,8-diol-9,10-epoxide at endogenous aprt gene in CHO cells. Somat Cell Mol Genet 14:393-400 (1988).
43. Maher VM, Patton JD, Yang J-L, Wang Y, Yang LU Aust AE, Bhattacharyya N, McCormick JJ. Mutations and homologous recombination induced in mammalian cells by metabolites of benzo[a]pyrene and 1-nitropyrene, Environ Health Perspect 76:33-39 (1987).
44. IARC, DNA Adducts:Identification and Biological Significance (Hemminki K, Dipple A, Shuker DEC, Kadlubar FF, Segerbäck D, Bartsch H, eds). IARC Scientific Publications No 125. Lyon:International Agency for Research on Cancer, 1994.
45. Phillips DH, Hewer A, Martin CN, Garner RC, King MM. Correlation of DNA adduct levels in human lung with cigarette smoking, Nature 336:790-792 (1988).
46. Phillips DH, Schoket B, Hewer A, Bailey E, Kostic S, Vincze I. Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells. Int J Cancer 46:569-575 (1990).
47. 32P-postlabelling:metabolic phenotype dependence and comparisons with other exposure markers. In:Postlabelling Methods for the Detection of DNA Damage (Phillips DH, Castegnaro M, Bartsch H, eds). IARC Scientific Publications No 124, Lyon:International Agency for Research on Cancer, 1993;331-340.
48. Cherpillod P, Amstad PA. Benzo[a]pyrene-induced mutagenesis of p53 hot-spot codons 248 and 249 in human hepatocytes. Mol Carcinog 13:15-20 (1995).
49. Ory K, Legros Y, Auguin C, Soussi T, Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of call proliferation, EMBO J 13(15):3496-3504 (1994).
50. Gao HG, Chen JK, Stewart J, Song B, Rayappa C, Whong WZ, Ong T. Distribution of p53 and K-ras mutations in human lung cancer tissues. Carcinogenesis 18:473-478 (1997).
51. Harty LC, Guinee DGJ, Travis WD, Bennett WP, Jett J, Colby TV, Tazelaar H, Trastek V, Pairolero P, Liotta LA, et al. p53 Mutations and occupational exposures in a surgical series of lung cancers. Cancer Epidemiol Biomarkers Prev 5(12):997-1003 (1996).
52. Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. Br J Cancer 315:980-988 (1997).